Growth hormone effects on insulin cells in adults with diabetes family history
Studies how growth hormone affects insulin-making pancreas cells in adults with family history.
Key facts
- Who runs it
- University of Missouri-Columbia
- Where
- Columbia, United StatesSee the site
- Trial code
- Registry title
- Growth Hormone Resistance of Beta-cells in People With a Family History of Type 2 Diabetes
- Status
- Recruiting
- People taking part
- 30 people, planned
- Started
- 15 Jul 2025
- Expected to end
- 1 Sept 2030
- Type of study
- Observational, 2 groups
- Record updated
- 11 May 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 18 to 59 with a body mass index of 30.0 or more and under 45.0. Some have a close relative with type 2 diabetes, and some are a control group without a family history.
- Age
- 18 to 59 years
- Sex
- All sexes
- Disease stage
- Body mass index of 30.0 kg/m2 or more and under 45.0 kg/m2. One group has a first degree relative with type 2 diabetes. The control group has no family history of type 2 diabetes.
- Earlier treatment
- Cannot have had bariatric surgery. Cannot use medicines that can affect the study results, for example GLP-1 receptor agonists.
Main reasons for not taking part
- Pregnant, planning pregnancy during the study, or breastfeeding
- Current or past type 1 or type 2 diabetes
- History of bariatric surgery
- Current cancer, or cancer in remission less than 5 years
- More than 3% weight loss within three months of screening
The registry criteria, word for word
Show all 16 criteriaShow less
Who can take part
- 18 to 59 years old
- body mass index ≥30.0 kg/m2 and <45.0 kg/m2; Additional, group-specific inclusion criteria:
- Family history of type 2 diabetes: first degree relative with type 2 diabetes
- Control group: no family history of type 2 diabetes
Who cannot take part
- Use of medications that can impact the study outcomes (e.g., GLP-1 receptor agonists)
- Current diagnosis or history of type 1 or type 2 diabetes
- History of bariatric surgery
- History of intracranial hypertension, including papilledema, or a condition that increases the risk of developing intracranial hypertension, such as Turner Syndrome, Prader-Willi Syndrome, or renal impairment
- Current cancer or cancer that has been in remission less than 5 years
- First degree relative with type 1 diabetes diagnosis
- Evidence of significant anemia or significant end organ dysfunction (e.g., liver, kidney, heart disease)
- Alcohol use disorder, use of controlled substances, or smoking >2 cigarettes per day
- Pregnant, planning to become pregnant during the study, or breastfeeding
- Known, uncontrolled hypothyroidism
- Greater than 3% weight loss within three months of screening or engaged in regular (≥3 days per week), continuous moderate- or high-intensity exercise of ≥30 min duration
- Mentally disabled persons, prisoners, and persons with inability to grant voluntary informed consent
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 59 years old?
Where in United States
- University of Missouri School of MedicineColumbia, United StatesContact: Bettina MittendorferTaking people
About the trial
What the trial wants to find out
The purpose of the research study is to better understand how beta-cells (cells in the pancreas that make insulin and help regulate blood sugar) respond to growth hormone in people with a family history of type 2 diabetes at the University of Missouri. Our aim is to advance understanding of how growth hormone affects beta-cells and risk factors for developing type 2 diabetes.
The 2 groups in the trial
- Men and women with a family history of type 2 diabetes
- Men and women without a family history of type 2 diabetes
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Growth Hormone Resistance of Beta-cells in People With a Family History of Type 2 Diabetes
- Plain-language title
- Growth hormone effects on insulin cells in adults with diabetes family historyGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT06571500, who can take part
- Record updated
- 11 May 2026